VIA
ISEE

Vident Investment Advisory’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Vident Investment Advisory’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-22,293
Closed -$877K – 1168
2023
Q2 		$877K Buy
+22,293
New +$787K 0.03% 517

Vident Investment Advisory's ISEE Position: Q3 2023 in Review

Vident Investment Advisory sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 22,293 shares — an estimated $877K sold.

Vident Investment Advisory first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $877K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Vident Investment Advisory reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 22,293 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $877K.
  • Vident Investment Advisory first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Vident Investment Advisory's IVERIC bio, Inc. Common Stock position peaked at $877K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.